Cure Pharmaceutical Holding Corp. CFO Michael Redard receives $1M in 2019
Cure Pharmaceutical Holding Corp. reports 2019 executive compensation
By ExecPay News
Published: August 7, 2020
Cure Pharmaceutical Holding Corp. reported fiscal year 2019 executive compensation information on August 7, 2020.
In 2019, four executives at Cure Pharmaceutical Holding Corp. received on average a compensation package of $570K, a 54% increase compared to previous year.
Average pay of disclosed executives at Cure Pharmaceutical Holding Corp.
Michael Redard, Chief Financial Officer, received $1M in total. 90% of Redard's compensation, or $925K, was in option awards. Redard also received $107K in salary.
Robert Davidson, Chief Executive Officer, received a compensation package of $933K, which increased by 100% compared to previous year. 79% of the compensation package, or $736K, was in option awards.
Jessica Rousset, Chief Operating Officer, earned $180K in 2019, a 59% decrease compared to previous year.
Mark Udell, Chief Accounting Officer, received $134K in 2019, which decreases by 34% compared to 2018.
Related executives
You may also like
Source: SEC filing on August 7, 2020.